Teladoc Q4 EPS Beats, Guides Q1 Sales Below Forecast; DB Sets $11 Target
Teladoc reported Q4 loss of $0.14 per share versus a $0.18 consensus loss and revenue of $642.3M beating forecasts. It guided Q1 loss of $0.35–0.45 and sales of $598M–620M below consensus estimates, while Deutsche Bank upgraded to Buy with an $11 target.
1. Stronger-Than-Expected Q4 Performance
Teladoc reported a loss of $0.14 per share versus a consensus loss of $0.18, with revenue rising 8% year-over-year to $642.3 million driven by a 24% increase in ancillary services despite a 4% decline in access fees.
2. Guidance Below Street Views
The company forecast a first-quarter loss of $0.35–0.45 per share on revenue of $598–620 million, below consensus estimates of a $0.25 loss and $633.8 million in sales, and sees full-year 2026 loss of $0.70–1.10 with $2.47–2.59 billion in revenue below the $2.55 billion consensus.
3. Analyst Ratings and Price Target Changes
Deutsche Bank upgraded to Buy with an $11 target citing a BetterHelp turnaround strategy, while Oppenheimer, Citi, Piper Sandler, BMO, Cowen, Leerink Partners and Canaccord Genuity maintained or lowered price targets in a range of $5 to $10 reflecting mixed sentiment.
4. Technical Indicators Show Mixed Momentum
Shares rose 5.6% to $5.59, trading 21.8% above the 20-day average but 12.5% below the 100-day, with RSI at 52.2 in neutral territory and MACD turning positive, suggesting potential breakouts near support at $5.00 and resistance at $6.50.